SCHEMBL87292

SCHEMBL87292

CCC(=O)Oc1ccc2c(c1)C(=O)CC(C)(C)S2

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 2/20 0.40
KMT2A Q03164 5/20 0.39
ESR1 P03372 2/20 0.39
HIF1A Q16665 2/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RECQL P46063 1/20 0.39
KDM4E B2RXH2 9/20 0.39
ALDH1A1 P00352 7/20 0.39
GAA P10253 5/20 0.39
HSD17B10 Q99714 4/20 0.39
HPGD P15428 4/20 0.39
CASP1 P29466 3/20 0.39
GLA P06280 4/20 0.37
CASP7 P55210 2/20 0.37
USP2 O75604 2/20 0.37
LMNA P02545 2/20 0.37
MAPK1 P28482 1/20 0.37
ELANE P08246 1/20 0.37
MAPT P10636 3/20 0.35
MEN1 O00255 2/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL85928 0.82 THRB (0.37) SMN1; SMN2KDM4EALDH1A1GAAHSD17B10
SCHEMBL1140756 0.81 ALDH1A1 (0.47) ACHEKMT2ASMN1; SMN2KDM4EALDH1A1
SCHEMBL10382360 0.72 HTT (0.42) KMT2ASMN1; SMN2ALDH1A1LMNAPOLB
SCHEMBL86972 0.72 KDM4E (0.39) KMT2ASMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL68066 0.70 VHL (0.50) KMT2ASMN1; SMN2RECQLKDM4EALDH1A1
SCHEMBL4255191 0.70 TDP2 (0.36) KMT2ARECQLKDM4EALDH1A1GAA
SCHEMBL12471284 0.70 MEN1 (0.47) KMT2ASMN1; SMN2KDM4EALDH1A1GAA
SCHEMBL12470715 0.69 ALDH1A1 (0.46) KMT2ASMN1; SMN2KDM4EALDH1A1HSD17B10
SCHEMBL727285 0.69 KDM4E (0.40) SMN1; SMN2KDM4EALDH1A1LMNAHTT
SCHEMBL1987343 0.69 ALDH1A1 (0.57) KMT2ASMN1; SMN2KDM4EALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2053095-B2 Ink composition and inkjet recording method using the same FUJIFILM CORP (JP) 2017-02-22 EP disclosed
EP-2053095-B1 Ink composition and inkjet recording method using the same FUJIFILM CORP (JP) 2014-03-26 EP disclosed
US-8129447-B2 Ink composition and inkjet recording method using the same FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
US-8129447-B2 Ink composition and inkjet recording method using the same FUJIFILM CORPORATION (JP) 2012-03-06 US disclosed
EP-2053095-A2 Ink composition and inkjet recording method using the same Fujifilm Corporation (JP) 2009-04-29 EP disclosed
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME FUJIFILM CORPORATION (JP) 2009-04-02 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090087575-A1 INK COMPOSITION AND INKJET RECORDING METHOD USING THE SAME RB1, IK, NOX1 ACHE 911/4885KMT2A 90/4885ESR1 194/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.